コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tion of active sleep (AS; also called REM or rapid eye movement sleep).
2 firing during active sleep (AS, also called rapid-eye-movement sleep).
3 derlying mechanism may be the suppression of rapid eye movement sleep.
4 kening event during both slow-wave sleep and rapid eye movement sleep.
5 ne of them regulates the circadian rhythm of rapid eye movement sleep.
6 ring wakefulness and to a lesser extent, non-rapid eye movement sleep.
7 eye movement sleep, and decreased or absent rapid eye movement sleep.
8 2 h, and did not occur during wakefulness or rapid eye movement sleep.
9 o wakefulness from either slow wave sleep or rapid eye movement sleep.
10 ility in thalamocortical networks during non-rapid eye movement sleep.
11 sponse are similar in wakefulness and in non-rapid eye movement sleep.
12 slow wave activity ipsilaterally during non-rapid eye movement sleep.
13 and not in a familiar environment or during rapid eye movement sleep.
14 s that occur during exploratory behavior and rapid eye movement sleep.
15 ents) or without (7 patients) CSA during non-rapid eye movement sleep.
16 tic phenomenon of paradoxical sleep (PS), or rapid eye movement sleep.
17 d a regionally selective reactivation during rapid eye movement sleep.
18 rns characterized by increased percentage of rapid eye movement sleep.
19 ncephalogram (EEG) signatures of stage 2 non-rapid eye movement sleep.
20 with skeletal muscle paralysis characterizes rapid eye movement sleep.
21 sleep and a reduction of delta power in non-rapid eye movement sleep.
22 efulness and had an increased propensity for rapid eye movement sleep.
23 wave activity decreased gradually during non-rapid eye movement sleep.
24 rat hippocampus during maze exploration and rapid eye movement sleep.
25 SFAs decreased wakefulness and increased non-rapid eye movement sleep.
26 y wakefulness at the expense of both SWS and rapid eye movement sleep.
27 are bursts of 11-15 Hz that occur during non-rapid eye movement sleep.
28 d eye movement sleep and greatly reduced non-rapid eye movement sleep.
29 are commonly observed during stage 2 of non-rapid eye movement sleep.
30 without disrupting non-rapid eye movement or rapid eye movement sleep.
31 the cortical states resembling slow-wave and rapid-eye-movement sleep.
32 on structure but only during wakefulness and rapid-eye-movement sleep.
33 ons across wakefulness, slow-wave sleep, and rapid-eye-movement sleep.
34 ear conditioning had less theta power during rapid-eye-movement sleep.
35 n, can disrupt sleep structure, particularly rapid-eye-movement sleep.
36 eep and (b) tonic activity during waking and rapid-eye-movement sleep.
37 me functional differences between waking and rapid-eye-movement sleep.
38 ically involved in the generation of active (rapid eye movement) sleep.
39 cataplexy or any indication of abnormal REM (rapid eye movement) sleep.
40 roencephalographic (EEG) activity during non-rapid eye movement sleep, a highly heritable trait with
41 ed between periods of presumed slow-wave and rapid-eye-movement-sleep/active-state, which were charac
42 y had an increase in NREMS and a decrease in rapid eye movement sleep after interleukin-1beta treatme
43 sis of V1, activation enhancement during non-rapid-eye-movement sleep after training was observed spe
45 ivity during both non-rapid eye movement and rapid eye movement sleep and a reduction of delta power
46 global deactivation of the brain during non rapid eye movement sleep and a regionally selective reac
47 ttern of alterations was not observed during rapid eye movement sleep and could not be easily explain
48 ot) over water method for SD that eliminated rapid eye movement sleep and greatly reduced non-rapid e
49 sms, which may underlie the promotion of non-rapid eye movement sleep and have implications for the u
51 e relative contribution of two sleep states, rapid eye movement sleep and slow-wave sleep, to offline
52 Among other OSA-related variables, AHI in rapid eye movement sleep and time spent with oxygen satu
53 tification pattern with a 400% increase from rapid eye movement sleep and wake, to light and deep sle
57 r task are reactivated during subsequent non-rapid eye movement sleep, and disrupting this neuronal r
58 n the spectral profile, observed only during rapid eye movement sleep, and only at the highest dose t
59 recordings are used to distinguish wake, non-rapid eye movement sleep, and rapid eye movement sleep s
60 delta power spectrum, produced low-delta non-rapid eye movement sleep, and slightly increased wakeful
61 ches and hypnic headache are associated with rapid eye movement sleep, as illustrated by recent polys
62 disease (PD), in 15 subjects with idiopathic rapid eye movement sleep behavior disorder (iRBD) and co
63 sporter (DAT) imaging to identify idiopathic rapid eye movement sleep behavior disorder (IRBD) patien
64 pical Parkinson syndromes (n=11), idiopathic rapid eye movement sleep behavior disorder (n=10), and h
68 atic hypotension, mild cognitive impairment, rapid eye movement sleep behavior disorder (RBD), depres
69 is downregulated in patients with idiopathic rapid eye movement sleep behavior disorder and antedates
72 eline, 0.65; mean follow-up, 2.88; P = .01), rapid eye movement sleep behavior disorder scores were s
73 eflected by supranuclear ophtalmoparesis and rapid eye movement sleep behavior disorder with underlyi
74 Some non-motor symptoms such as hyposmia, rapid eye movement sleep behavior disorder, and constipa
75 ve daytime sleepiness, insomnia, narcolepsy, rapid eye movement sleep behavior disorder, and restless
76 rum samples from 56 patients with idiopathic rapid eye movement sleep behavior disorder, before and a
77 kers using standardized scales for hyposmia, rapid eye movement sleep behavior disorder, depression,
79 mes in Parkinson's Disease (SCOPA-AUT), REM (Rapid Eye Movement) Sleep Behavior Disorder Single-Quest
80 ients (age 65.0+/-5.6 years) with idiopathic rapid eye movement sleep behaviour disorder and 21 age/g
82 glia network dysfunction differentiated both rapid eye movement sleep behaviour disorder and Parkinso
83 nnectivity, and for loss of tracer uptake in rapid eye movement sleep behaviour disorder and Parkinso
84 lso elevated (P<0.0001) in the patients with rapid eye movement sleep behaviour disorder but lower th
86 depression, excessive daytime sleepiness, or rapid eye movement sleep behaviour disorder in early Par
87 sy-proven Lewy body disease, indicating that rapid eye movement sleep behaviour disorder plus mild co
89 m baseline was observed, as reflected in the Rapid Eye Movement Sleep Behaviour Disorder Questionnair
90 roved by addition of clinical scores (UPSIT, Rapid Eye Movement Sleep Behaviour Disorder Screening Qu
91 c networks may provide markers of idiopathic rapid eye movement sleep behaviour disorder to identify
95 tients with polysomnographically-established rapid eye movement sleep behaviour disorder, 48 patients
96 h sensitivity (96%) and specificity (74% for rapid eye movement sleep behaviour disorder, 78% for Par
97 changes are present in so-called idiopathic rapid eye movement sleep behaviour disorder, a condition
98 ange) for specific features were: seven with rapid eye movement sleep behaviour disorder-60 years (27
103 pression, apathy, sleep disorders (including rapid-eye movement sleep behaviour disorder), and erecti
104 igue, insomnia, anosmia, hypersalivation and rapid-eye-movement sleep behaviour disorder) in the year
105 t determinants of visual hallucinations were rapid eye movement sleep behavioural disorder (P = 0.026
106 ical features of Parkinson's disease such as rapid eye movement sleep behavioural disorder and the po
107 particular excessive daytime somnolence and rapid eye movement sleep behavioural disorder, disorders
108 (PET(CO2)) was gradually reduced during non-rapid eye movement sleep by increasing tidal volume with
110 hr, orexin KO mice recovered their NREM and rapid eye movement sleep deficits at comparable rates an
113 orexant were observed in wakefulness and non-rapid eye movement sleep during both dark and light phas
114 akefulness promotes slow-wave sleep, but not rapid eye movement sleep, during a period of low sleep p
115 as clonazepam did the opposite, reducing non-rapid eye movement sleep EEG instability without effects
117 ng a paradigm designed to mimic intermittent rapid eye movement sleep epochs, we show that applicatio
120 ring by lights-off and redistribution of non-rapid eye movement sleep in short light-dark cycles.
121 taplectic arrests and other abnormalities of rapid eye movement sleep in the absence of endogenous or
125 use orexin promotes wakefulness and inhibits rapid eye movement sleep, its absence may permit inappro
128 evidence suggests that the slow waves of non-rapid eye movement sleep may function as markers to trac
130 in abnormalities in the brainstem disinhibit rapid eye movement sleep motor activity, leading to drea
131 aking that are thought to be an intrusion of rapid eye movement sleep muscle atonia into wakefulness.
133 ripples (80-200 Hz) chiefly occur during non-rapid eye movement sleep (NREM), and that ripple oscilla
134 primary brain vigilance states (waking, non-rapid eye movement sleep [NREM] and REM sleep) within an
135 phic (EEG) delta power during subsequent non-rapid eye movement sleep (NREMS) and is associated with
136 EEG slow wave power ipsilaterally during non-rapid eye movement sleep (NREMS) but not during REMS or
137 fusion induced a progressive decrease in non-rapid eye movement sleep (NREMS) during the 4-week perio
138 TNFalpha dose-dependently increased non-rapid eye movement sleep (NREMS) in the controls but did
139 tivity of thalamocortical origin; during non-rapid eye movement sleep (NREMS), activity in the spindl
140 ormone-releasing hormone (GHRH) promotes non-rapid eye movement sleep (NREMS), in part via a well cha
141 gonist, induced significant increases in non-rapid-eye movement sleep (NREMS) lasting for 4-10 h.
142 dent reductions in respiratory events in non-rapid-eye-movement sleep (NREMS) and rapid-eye-movement
143 ection of the immunotoxin, the amount of non-rapid-eye-movement sleep (NREMS) and rapid-eye-movement
144 ine cholinergic neurones, which control REM (rapid eye movement) sleep or dreaming, is likely to cont
145 ncreased slow wave activity power during non-rapid eye movement sleep over widespread, bilateral scal
148 eep quality, increased percentage of time in rapid eye movement sleep, pain at night at least three t
149 showed an alternating non-rapid eye movement/rapid eye movement sleep pattern and a homoeostatic decl
150 trast, frequent interictal spikes during non-rapid eye movement sleep predicted a reduced homeostatic
151 lectroencephalogram (delta power) during non-rapid eye movement sleep reflects homeostatic sleep need
152 ntain wakefulness and abnormal intrusions of rapid eye movement sleep-related phenomena into wakefuln
154 mic peptides Hypocretin/Orexin (Hcrt/Orx) to rapid eye movement sleep (REM) control and the sleep dis
156 C) produce relatively selective decreases in rapid eye movement sleep (REM) in mice that vary with st
157 LY379268 (LY37), dose-dependently suppresses rapid eye movement sleep (REM) whereas systemic administ
161 siological states, slow-wave sleep (SWS) and rapid-eye-movement sleep (REM), often identified by the
163 ss produces a sexually dimorphic increase in rapid eye movement sleep (REMS) amount in mice that is g
165 ular mechanisms that determine the amount of rapid eye movement sleep (REMS) and non-REMS (NREMS) rem
166 a 30% reduction in time spent in spontaneous rapid eye movement sleep (REMS) as a consequence of a re
171 Br-cGMP increased wakefulness and suppressed rapid-eye-movement sleep (REMS) and non-REMS (NREMS) in
172 of non-rapid-eye-movement sleep (NREMS) and rapid-eye-movement sleep (REMS) increased during the dar
175 generalization of partial seizures, however rapid-eye-movement sleep seems to suppress seizures.
176 oss the night for non-rapid eye movement and rapid eye movement sleep separately were classified usin
180 into wakefulness of physiological aspects of rapid eye movement sleep such as cataplexy and hallucina
181 d intact, males had more total sleep and non-rapid eye movement sleep than females during the active
182 ith the phenomenology and neurophysiology of rapid eye movement sleep, the early and acute psychotic
186 in slow wave sleep time (45 min vs 28 min), rapid eye movement sleep time (11 min vs 3 min), or the
187 dopamine transporter (DAT) gene reduced non-rapid eye movement sleep time and increased wakefulness
188 e movement (NREM) delta power] and increased rapid eye movement sleep time compared with baseline.
189 pportunities and failed to increase NREM and rapid eye movement sleep times, despite accumulating a s
190 ranial magnetic stimulation (TMS) during non-rapid eye movement sleep to examine whether the spontane
191 iring is prominent, whereas during waking or rapid eye movement sleep, tonic, single-spike activity d
192 the effects of light on behavior, including rapid eye movement sleep triggering by lights-off and re
193 The lowest oxygen saturation measured during rapid eye movement sleep was 78 +/- 5% preoperatively an
194 characteristic change in PET,CO2 during non-rapid eye movement sleep was shown to be independent of
195 w-frequency (0.5-2.0 Hz) oscillations in non-rapid-eye-movement sleep, was significantly larger in th
196 Latencies of late RVLMS responses during rapid eye movement sleep were significantly longer than
198 as well as a theta power (4-7Hz) decrease in rapid eye movement sleep, were associated with disease b
199 ons, recorded during either wheel running or rapid eye movement sleep, were not different either.
200 ation were present during both slow-wave and rapid-eye movement sleep, were repeatedly observed over
201 ifted progressively from 7 Hz to 6 Hz during rapid eye movement sleep, whereas slow wave activity dec
202 e predatorylike attack sometimes observed in rapid eye movement sleep without atonia (REM-A), created
203 y clinical features and the demonstration of rapid eye movement sleep without atonia on polysomnograp
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。